{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:02:08Z","timestamp":1740124928615,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1038\/s41433-024-03413-6","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T20:18:26Z","timestamp":1732220306000},"page":"4-6","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pilot and feasibility studies in ophthalmology: fundamental keys to success"],"prefix":"10.1038","volume":"39","author":[{"given":"Keean","family":"Nanji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0923-261X","authenticated-orcid":false,"given":"Mark","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lehana","family":"Thabane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6752-797X","authenticated-orcid":false,"given":"Yih Chung","family":"Tham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tien Yin","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8734-3089","authenticated-orcid":false,"given":"David H.","family":"Steel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion R.","family":"Munk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles C.","family":"Wykoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9988-4146","authenticated-orcid":false,"given":"Varun","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"On behalf of the Retina Evidence and Trials INternational Alliance (R.E.T.I.N.A.) Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varun","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohit","family":"Bhandari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles C.","family":"Wykoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sobha","family":"Sivaprasad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lehana","family":"Thabane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Sarraf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie J.","family":"Bakri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunir J.","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rishi P.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank G.","family":"Holz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tien Y.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robyn H.","family":"Guymer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David H.","family":"Steel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SriniVas R.","family":"Sadda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,21]]},"reference":[{"key":"3413_CR1","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.cct.2014.04.001","volume":"38","author":"AL Whitehead","year":"2014","unstructured":"Whitehead AL, Sully BGO, Campbell MJ. Pilot and feasibility studies: Is there a difference from each other and from a randomised controlled trial? Contemp Clin Trials. 2014;38:130\u20133.","journal-title":"Contemp Clin Trials."},{"key":"3413_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-10-1","volume":"10","author":"L Thabane","year":"2010","unstructured":"Thabane L, Ma J, Chu R, Cheng J, Ismaila A, Rios LP, et al. A tutorial on pilot studies: the what, why and how. BMC Med Res Methodol. 2010;10:1.","journal-title":"BMC Med Res Methodol."},{"key":"3413_CR3","unstructured":"Teijlingen ER, Hundley V. Social Research Update 35: The importance of pilot studies. Soc. Res. Updat. 2001. Available at: https:\/\/sru.soc.surrey.ac.uk\/SRU35.html [Accessed December 12, 2023]."},{"key":"3413_CR4","doi-asserted-by":"publisher","first-page":"e0150205","DOI":"10.1371\/journal.pone.0150205","volume":"11","author":"SM Eldridge","year":"2016","unstructured":"Eldridge SM, Lancaster GA, Campbell MJ, Thabane L, Hopewell S, Coleman CL, et al. Defining Feasibility and Pilot Studies in Preparation for Randomised Controlled Trials: Development of a Conceptual Framework. PLoS One. 2016;11:e0150205 https:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0150205. Accessed October 6, 2023.","journal-title":"PLoS One"},{"key":"3413_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40814-023-01233-1","volume":"9","author":"C Bond","year":"2023","unstructured":"Bond C, Lancaster GA, Campbell M, Chan C, Eddy S, Hopewell S, et al. Pilot and feasibility studies: extending the conceptual framework. Pilot Feasibility Stud. 2023;9:1\u201310. https:\/\/pilotfeasibilitystudies.biomedcentral.com\/articles\/10.1186\/s40814-023-01233-1. Accessed July 14, 2024.","journal-title":"Pilot Feasibility Stud"},{"key":"3413_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40814-020-00634-w","volume":"6","author":"N Pearson","year":"2020","unstructured":"Pearson N, Naylor PJ, Ashe MC, Fernandez M, Yoong SL, Wolfenden L. Guidance for conducting feasibility and pilot studies for implementation trials. Pilot Feasibility Stud. 2020;6:1\u201312. https:\/\/pilotfeasibilitystudies.biomedcentral.com\/articles\/10.1186\/s40814-020-00634-w. Accessed October 6, 2023.","journal-title":"Pilot Feasibility Stud"},{"key":"3413_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40814-023-01288-0","volume":"9","author":"A Airody","year":"2023","unstructured":"Airody A, Baseler HA, Seymour J, Allgar V, Mukherjee R, Downey L, et al. The MATE trial: a multicentre, mixed-methodology, pilot, randomised controlled trial in neovascular age-related macular degeneration. Pilot Feasibility Stud. 2023;9:1\u201314. https:\/\/pilotfeasibilitystudies.biomedcentral.com\/articles\/10.1186\/s40814-023-01288-0. Accessed October 6, 2023.","journal-title":"Pilot Feasibility Stud"},{"key":"3413_CR8","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.4103\/ijo.IJO_3085_21","volume":"70","author":"N Davara","year":"2022","unstructured":"Davara N, Chintoju R, Manchikanti N, Thinley C, Vaddavalli P, Rani P, et al. Feasibility study for measuring patients\u2019 visual acuity at home by their caregivers. Indian J Ophthalmol 2022;70:2125\u201330. https:\/\/pubmed.ncbi.nlm.nih.gov\/35647997\/. Accessed October 6, 2023.","journal-title":"Indian J Ophthalmol"},{"key":"3413_CR9","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/S0140-6736(09)60329-9","volume":"374","author":"I Chalmers","year":"2009","unstructured":"Chalmers I, Glasziou P. Avoidable waste in the production and reporting of research evidence. Lancet. 2009;374:86\u201389. http:\/\/www.thelancet.com\/article\/S0140673609603299\/fulltext. Accessed December 12, 2023.","journal-title":"Lancet"},{"key":"3413_CR10","doi-asserted-by":"crossref","unstructured":"Scherer RW, Langenberg P, Von Elm E. Full publication of results initially presented in abstracts. Cochrane database Syst. Rev. 2007;2. Available at: https:\/\/pubmed.ncbi.nlm.nih.gov\/17443628\/. Accessed December 12, 2023.","DOI":"10.1002\/14651858.MR000005.pub3"},{"key":"3413_CR11","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1046\/j.1365-2648.2001.01757.x","volume":"34","author":"ER Van Teijlingen","year":"2001","unstructured":"Van Teijlingen ER, Rennie AM, Hundley V, Graham W. The importance of conducting and reporting pilot studies: the example of the Scottish Births Survey. J Adv Nurs. 2001;34:289\u201395. https:\/\/onlinelibrary-wiley-com.myaccess.library.utoronto.ca\/doi\/full\/10.1046\/j.1365-2648.2001.01757.x. Accessed December 12, 2023.","journal-title":"J Adv Nurs"},{"key":"3413_CR12","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1001\/jama.2015.10962","volume":"314","author":"C Kistin","year":"2015","unstructured":"Kistin C, Silverstein M. Pilot Studies: A Critical but Potentially Misused Component of Interventional Research. JAMA. 2015;314:1561.","journal-title":"JAMA"},{"key":"3413_CR13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4103\/0019-5413.30521","volume":"41","author":"M Zlowodzki","year":"2007","unstructured":"Zlowodzki M, J\u00f6nsson A, Kregor PJ, Bhandari M. How to write a grant proposal. Indian J Orthop. 2007;41:23.","journal-title":"Indian J Orthop"},{"key":"3413_CR14","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.jpsychires.2010.10.008","volume":"45","author":"AC Leon","year":"2011","unstructured":"Leon AC, Davis LL, Kraemer HC. The Role and Interpretation of Pilot Studies in Clinical Research. J Psychiatr Res. 2011;45:626.","journal-title":"J Psychiatr Res"},{"key":"3413_CR15","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1038\/s41433-022-02324-8","volume":"37","author":"A Azuara-Blanco","year":"2023","unstructured":"Azuara-Blanco A, Carlisle A, Jayaram H, Gazzard G, Larkin DFP, Wickham L, et al. Surgical innovation in ophthalmology: challenges and opportunities. Eye. 2023;37:2165.","journal-title":"Eye"},{"key":"3413_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40814-019-0493-7","volume":"5","author":"J Sim","year":"2019","unstructured":"Sim J. Should treatment effects be estimated in pilot and feasibility studies? Pilot Feasibility Stud. 2019;5:1\u20137. https:\/\/pilotfeasibilitystudies.biomedcentral.com\/articles\/10.1186\/s40814-019-0493-7. Accessed December 12, 2023.","journal-title":"Pilot Feasibility Stud"},{"key":"3413_CR17","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j..2002.384.doc.x","volume":"10","author":"GA Lancaster","year":"2004","unstructured":"Lancaster GA, Dodd S, Williamson PR. Design and analysis of pilot studies: recommendations for good practice. J Eval Clin Pr. 2004;10:307\u201312. https:\/\/pubmed-ncbi-nlm-nih-gov.libaccess.lib.mcmaster.ca\/15189396\/. Accessed February 21, 2022.","journal-title":"J Eval Clin Pr"},{"key":"3413_CR18","doi-asserted-by":"crossref","unstructured":"Avery KNL, Williamson PR, Gamble C, Francischetto EOC, Metcalfe C, Davidson P, et al. Informing efficient randomised controlled trials: exploration of challenges in developing progression criteria for internal pilot studies. BMJ Open. 2017;7:e013537.","DOI":"10.1136\/bmjopen-2016-013537"},{"key":"3413_CR19","doi-asserted-by":"crossref","unstructured":"Morgan B, Hejdenberg J, Hinrichs-Krapels S, Armstrong D. Do feasibility studies contribute to, or avoid, waste in research? PLoS One. 2018;13:e0195951.","DOI":"10.1371\/journal.pone.0195951"},{"key":"3413_CR20","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1177\/1740774517752113","volume":"15","author":"CL Cooper","year":"2018","unstructured":"Cooper CL, Whitehead A, Pottrill E, Julious SA, Walters SJ. Are pilot trials useful for predicting randomisation and attrition rates in definitive studies: A review of publicly funded trials. Clin Trials. 2018;15:189\u201396. https:\/\/pubmed.ncbi.nlm.nih.gov\/29361833\/. Accessed July 14, 2024.","journal-title":"Clin Trials."},{"key":"3413_CR21","doi-asserted-by":"crossref","unstructured":"Abbott JH. The Distinction Between Randomized Clinical Trials (RCTs) and Preliminary Feasibility and Pilot Studies: What They Are and Are Not. J Orthop Sports Phys Ther. 2014;44:555\u20138.","DOI":"10.2519\/jospt.2014.0110"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03413-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03413-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03413-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T20:11:26Z","timestamp":1736885486000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03413-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,21]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["3413"],"URL":"https:\/\/doi.org\/10.1038\/s41433-024-03413-6","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"type":"print","value":"0950-222X"},{"type":"electronic","value":"1476-5454"}],"subject":[],"published":{"date-parts":[[2024,11,21]]},"assertion":[{"value":"2 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"KN: None. MP: None. LT: None. YCT: None. TYW: Professor Wong is a consultant for Astellas, Bayer, Boehringer-Ingelheim, Genentech, Iveric Bio, Novartis, Oxurion, Plano, Roche, Sanofi, and Shanghai Henlius. He is an inventor, holds patents and is a co-founder of start-up companies EyRiS and Visre, which have interests in, and develop digital solutions for eye diseases. DHS: Consultant: Gyroscope, Roche, Alcon, BVI; Research funds: Alcon, Bayer, DORC, Gyrsocope, Boehringer-Ingelheim. MRM: Consultant for Abbvie, Allergan, Apellis, Alimera, Bayer, Zeiss, Lumithera, Novartis, Oculis, Ocuterra, Gensight Therapeutics, RetinAI, Isarna Therapeutics, Kubota, Roche, B\u00f6hringer-Ingelheim, Dandelion, Eyepoint, Iveric Bio. CW: Dr. Wykoff reported consulting for 4DMT, AbbVie, Adverum, Alcon, Alimera, Alkeus, Annexon, Apellis, Aviceda, Bayer, Biocryst, Boehringer Ingelheim, Clearside, EyeBiotech, EyePoint, Genentech, InGel, Janssen, Kiora, KodiakMerck, Neurotech, Novartis, Ocuphire, ONL, Opthea, Osanni, Panther, Perceive Bio, Ray, Regeneron, RegenXBio, Sanofi, Santen, Stealth, Valo, Zeiss. VC: Dr. Chaudhary reports acting as an advisory board member, grants and other from Novartis; acting as an advisory board member, grants and other from Bayer; grants from Allergan; acting as an advisory board member and grants from Roche; acting as an advisory board member for Janssen; acting as an advisory board member for Apellis; and acting as an advisory board member for Boehringer Ingelheim outside the submitted work. Dr. Chaudhary is also a current member of the Eye editorial board.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}